Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury

Journal of Comparative Neurology

Volumn 494, Issue 4, 2006, Pages 578-594

  Kigerl, Kristina A ^a   McGaughy, Violeta M ^a   Popovich, Phillip G ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b 2078 Graves Hall   (United States)

Author keywords

Macrophage; Mouse; Neuroinflammation; Spinal cord injury; Strain differences; T cell; Wound healing

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE ANATOMY; CONTROLLED STUDY; CONTUSION; GENETIC SUSCEPTIBILITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; SPINE INJURY; STEREOLOGY; STRAIN DIFFERENCE; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; MACROPHAGES; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROGLIA; SPECIES SPECIFICITY; SPINAL CORD INJURIES;

EID: 30144445614     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20827     Document Type: Article

References (82)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562.
2. Baecher-Allan CM, Barth RK. 1993. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg Immunol 5:207-217.
3. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491.
4. Bao F, Chen Y, Dekaban GA, Weaver LC. 2004. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 88:1335-1344.
5. Bartholdi D, Schwab ME. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9:1422-1438.
6. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, Bresnahan JC, Hempstead BL, Yoon SO. 2002. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36:375-386.
7. Bernard CC. 1976. Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J Immunogenet 3:263-274.
8. Bhattacharya A, Dorf ME, Springer TA. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subrogions: evidence for I region gene duplication. J Immunol 127:2488-2495.
9. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. 1994. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71-81.
10. Campbell EJ, Senior RM, McDonald JA, Cox DL. 1982. Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J Clin Invest 70:845-852.
11. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Neuroimmunol 149:2736-2741.
12. Charles PC, Weber KS, Cipriani B, Brosnan CF. 1999. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J Neuroimmunol 100:64-73.
13. Cross AH, Cannella B, Brosnan CF, Raine CS. 1990. Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of C14-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63:162-170.
14. Dallegri F, Ottonello L. 1997. Tissue injury in neutrophilic inflammation. Inflamm Res 46:382-391.
15. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A 88:6368-6371.
16. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA, Walczak H, Falk W, Essig M, Edler L, Krammer PH, Martin-Villalba A. 2004. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 10:389-395.
17. Duleu S, Vincendeau P, Courtois P, Semballa S, Lagroye I, Daulouede S, Boucher JL, Wilson KT, Veyret B, Gobert AP. 2004. Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect. J Immunol 172:6298-6303.
18. Dusart I, Schwab ME. 1994. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712-724.
19. Franko AJ, Sharplin J, Ghahary A, Barcellos-Hoff MH. 1997. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non- fibrosing" mice during the latent period and early phase after irradiation. Radiat Res 147:245-256.
20. Fritz RB, Skeen MJ, Chou CH, Garcia M, Egorov IK. 1985. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 134:2328-2332.
21. Gharaee-Kermani M, Phan SH. 2001. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 7:1083-1103.
22. Gonzalez R, Glaser J, Liu MT, Lane TE, Keirstead HS. 2003. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 184:456-463.
23. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Duboia CM, Kopp WC, Longo DL, Keller JR. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147:22-28.
24. Hickey WF, Osborn JP, Kirby WM. 1985. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol 91:528-535.
25. Hirsch S, Gordon S. 1983. Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 18:229-239.
26. Howard CV, Reed MG. 1998. Unbiased stereology: three-dimensional measurement in microscopy. New York: Springer-Verlag.
27. Inman DM, Steward O. 2003. Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice. J Comp Neurol 462:431-449.
28. Inman D, Guth L, Steward O. 2002. Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice. J Comp Neurol 451:225-235.
29. Jakeman LB, Guan Z, Wei P, Ponnappan R, Dzwonczyk R, Popovich PG, Stokes BT. 2000. Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma 17:299-319.
30. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG. 2002. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22:2690-2700.
31. Jones TB, Hart RP, Popovich PG. 2005. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci 25:6576-6583.
32. Jutila MA, Kroese FG, Jutila KL, Stall AM, Fiering S, Herzenberg LA, Berg EL, Butcher EC. 1988. Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur J Immunol 18:1819-1826.
33. Kerr BJ, Patterson PH. 2004. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188:391-407.
34. Kim JE, Li S, GrandPre T, Qiu D, Strittmatter SM. 2003. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38:187-199.
35. Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. 2001. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci 21:4564-4571.
36. Kleba BJ, Banta E, Lindquist EA, Stephens RS. 2002. Recruitment of mammalian cell fibronectin to the surface of Chlamydia trachomatis. Infect Immun 70:3935-3938.
37. Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J. 2002. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 27:141-150.
38. Kuhn PL, Wrathall JR. 1998. A mouse model of graded contusive spinal cord injury. J Neurotrauma 15:125-140.
39. Linthicum DS, Frelinger JA. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med 156:31-40.
40. Ma M, Wei T, Boring L, Charo IF, Ransohoff RM, Jakeman LB. 2002. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion. J Neurosci Res 68:691-702.
41. Ma M, Wei P, Wei T, Ransohoff RM, Jakeman LB. 2004. Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response. J Comp Neurol 474:469-486.
42. Maron R, Hancock WW, Slavin A, Hattori M, Kuchroo V, Weiner HL. 1999. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int Immunol 11:1573-1580.
43. Mendel I, Kerlero de Rosbo N, Ben-Nun A. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur J Immunol 25:1951-1959.
44. Miescher GC, Schreyer M, MacDonald HR. 1989. Production and characterization of a rat monoclonal antibody against the murine CD3 molecular complex. Immunol Lett 23:113-118.
45. Munoz JJ, Mackay IR. 1984. Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant. J Neuroimmunol 7:91-96.
46. Natsume A, Mizuno M, Ryuke Y, Yoshida J. 1999. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Ther 6:1626-1633.
47. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. 2002. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 22:7526-7535.
48. Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, Iwamoto Y, Yoshizaki K, Kishimoto T, Toyama Y, Okano H. 2004. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76:265-276.
49. Olby NJ, Blakemore WF. 1996. A new method of quantifying the extent of tissue loss following spinal cord injury in the rat. Exp Neurol 138:82-92.
50. Olsson T, Dahlman I, Wallstrom E, Weissert R, Piehl F. 2000. Genetics of rat neuroinflammation. J Neuroimmunol 107:191-200.
51. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426:671-676.
52. Ousman SS, David S. 2001. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21:4649-4656.
53. Perrin FE, Lacroix S, Aviles-Trigueros M, David S. 2005. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 128:854-866.
54. Peterszegi G, Dagonet FB, Labat-Robert J, Robert L. 2002. Inhibition of cell proliferation and fibronectin biosynthesis by Na ascorbate. Eur J Clin Invest 32:372-380.
55. Popovich PG, Hickey WF. 2001. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 60:676-685.
56. Popovich PG, Horner PJ, Mullin BB, Stokes BT. 1996. A quantitative spatial analysis of the blood-spinal cord barrier I. Permeability changes after experimental spinal contusion injury. Exp Neurol 142:258-275.
57. Popovich PG, Wei P, Stokes BT. 1997. The cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464.
58. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158:351-365.
59. Popovich PG, van Rooijen N, Hickey WF, Preidis G, McGaughy V. 2003. Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol 182:275-287.
60. Qin SX, Wise M, Cobbold SP, Leong L, Kong YC, Parnes JR, Waldmann H. 1990. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 20:2737-2745.
61. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. 2001. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18:513-522.
62. Raine CS. 1984. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50:608-635.
63. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc Natl Acad Sci U S A 94:4103-4108.
64. Seabrook TJ, Johnston M, Hay JB. 1998. Cerebral spinal fluid lymphocytes are part of the normal recirculating lymphocyte pool. J Neuroimmunol 91:100-107.
65. Shaw MK, Kim C, Ho KL, Lisak RP, Tse HY. 1992. A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J Neuroimmunol 39:139-149.
66. Shi Z, Wakil AE, Rockey DC. 1997. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94:10663-10668.
67. Shuman SL, Bresnahan JC, Beattie MS. 1997. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 50:798-808.
68. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, van der PH, Schwab ME. 2003. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38:201-211.
69. Slobodov U, Reichert F, Mirski R, Rotshenker S. 2001. Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. Exp Neurol 167:401-409.
70. Springer T, Galfre G, Secher DS, Milstein C. 1979. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9:301-306.
71. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462:223-240.
72. Steward O, Schauwecker PE, Guth L, Zhang Z, Fujiki M, Inman D, Wrathall J, Kempermann G, Gage FH, Saatman KE, Raghupathi R, McIntosh TK. 1999. Genetic approaches to neurotrauma research:opportunities and potential pitfalls of murine models. Exp Neurol 157:19-42.
73. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K. 1997. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79:1177-1182.
74. Tjoa T, Strausbaugh HJ, Maida N, Dazin PF, Rosen SD, Noble-Haeusslein LJ. 2003. The use of flow cytometry to assess neutrophil infiltration in the injured murine spinal cord. J Neurosci Methods 129:49-59.
75. Tonai T, Shiba K, Taketani Y, Ohmoto Y, Murata K, Muraguchi M, Ohsaki H, Takeda E, Nishisho T. 2001. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J Neurochem 78:1064-1072.
76. Tuohy VK, Sobel RA, Lees MB. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J Immunol 140:1868-1873.
77. Turck CW, Dohlman JG, Goetzl EJ. 1987. Immunological mediators of wound healing and fibrosis. J Cell Physiol Suppl 5:89-93.
78. Wells JE, Rice TK, Nuttall RK, Edwards DR, Zekki H, Rivest S, Yong VW. 2003. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J Neurosci 23:10107-10115.
79. White P, Liebhaber SA, Cooke NE. 2002. 129X1/SvJ mouse strain has a novel defect in inflammatory cell recruitment. J Immunol 168:869-874.
80. Zehntner SP, Brickman C, Bourbonniere L, Remington L, Caruso M, Owens T. 2005. Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol 174:5124-5131.
81. Zhang Z, Fujiki M, Guth L, Steward O. 1996. Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J Comp Neurol 371:485-495.
82. Zheng B, Ho C, Li S, Keirstead H, Steward O, Tessier-Lavigne M. 2003. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 38:213-224.